The Effect of SGLT2 Inhibitors on Heart Rate Variability and BDNF Levels in Patients With Type 2 Diabetes
Condition(s):Type 2 Diabetes; Heart Rate VariabilityLast Updated:September 5, 2023Completed
Hide Studies Not Open or Pending
Condition(s):Type 2 Diabetes; Heart Rate VariabilityLast Updated:September 5, 2023Completed
Condition(s):Diabetes Mellitus, Type 2; ObesityLast Updated:October 5, 2023Recruiting
Condition(s):Chronic Kidney Disease; Type 2 DiabetesLast Updated:March 3, 2017Terminated
Condition(s):Gamification; Type 2 Diabetes; Self-management; Digital Health; Mobile ApplicationLast Updated:February 13, 2023Recruiting
Condition(s):Diabetes Mellitus, Type 2; Antioxidant Enzyme SystemLast Updated:November 14, 2017Completed
Condition(s):Chronic Kidney Disease; Type 2 Diabetes; Diabetic NephropathyLast Updated:February 2, 2024Completed
Condition(s):Diabetes Mellitus, Type 2Last Updated:January 12, 2024Not yet recruiting
Condition(s):Type 2 Diabetes Mellitus; Coronary AtherosclerosisLast Updated:May 31, 2019Completed
Condition(s):Type2 DiabetesLast Updated:February 15, 2017Completed
Condition(s):Type 2 Diabetes MellitusLast Updated:October 31, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.